Atlas Trials

Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study

Clinical trial NCT02271165 · TERMINATED

Trial details

NCT number
NCT02271165
Sponsor
Thomas Jefferson University
Status
TERMINATED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Dermatomyositis
Start date
2014-11-01
Primary completion
2017-03-02
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.